Application of Sequential Design of Experiments to Develop Ibuprofen (400 mg) Tablets by Direct Compression

Abstract

A strategy based on sequential design of experiments (screening, optimization and confirmation) was used to develop a tablet formulation of ibuprofen (400 mg) that is manufactured by direct compression. This formulation has a high content of ibuprofen (76%), in spite of the poor flowability of the drug substance. Sequential design of experiments proved to be an effective and efficient strategy in formulation development. 

Download
Application of Sequential Design of Experiments to Develop Ibuprofen (400 mg) Tablets by Direct Compression
Socorro Alpizar-Ramos1 and Mario González-de la Parra2*
1School of Chemistry, Universidad Nacional Autonoma de Mexico (UNAM), Mexico City, Mexico 2Biokinetics, S.A. de C.V., Mexico City, Mexico; mdelaparra@biokinetics.com.mx
15496-16955-1-PB.pdf
Adobe Acrobat Document 240.6 KB

Write a comment

Comments: 0